Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Cardiomyopathy_Paediatric

Gene: JPH2

Amber List (moderate evidence)

JPH2 (junctophilin 2, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000149596
EnsemblGeneIds (GRCh37): ENSG00000149596
OMIM: 605267, ClinGen, DECIPHER
JPH2 is in 6 panels

3 reviews

Carlos Smith-Diaz (Ingles Lab, Garvan Institute of Medical Research)

Green List (high evidence)

JPH2 has a robust gene-disease relationship with autosomal recessive paediatric dilated cardiomyopathy (DCM), with decreased gene-dosage being the established disease-causing mechanism.

Biallelic JPH2 loss-of-function causes severe paediatric-onset DCM with many patients progressing to transplantation. Reported cases primarily comprise patients with homozygous truncating variants predicted to undergo nonsense-mediated decay (NMD). Notable cases include the following:

1. A paediatric patient with DCM who died while awaiting a transplant, carrying the homozygous c.1920dup, p.(Glu641Ter) variant (Jones et al. 2019, PMID: 31227780);

2. A paediatric patient with DCM who received a heart transplant, carrying the homozygous c.1282C>T, p.(Gln428Ter) variant (Vasilescu et al. 2018, PMID: 30384889);

3. A paediatric patient diagnosed with DCM, carrying the homozygous c.1426G>T, p.(Glu476Ter) variant (Mehaney et al. 2022, PMID: 34036930);

4. A paediatric patient diagnosed with DCM, carrying the homozygous c.575C>A, p.(Ser192Ter) variant (Janin et al. 2022, PMID: 35838873); and

5. A paediatric patient diagnosed with DCM who underwent heart transplantation carrying compound heterozygous loss-of-function variants: an NMD-compliant frameshift variant (c.1359_1360insC, p.(Asp454ArgfsTer23) and an inversion displacing the 3’UTR) (Smith-Diaz, et al. 2026, doi: https://doi.org/10.64898/2026.06.16.26355718)
Created: 14 Sep 2026, 11:14 a.m. | Last Modified: 14 Sep 2026, 11:14 a.m.
Panel Version: 1.359

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Dilated Cardiomyopathy

Publications

Zornitza Stark (Victorian Clinical Genetics Services)

I don't know

Association with DCM: Several families with DCM and variants in this gene, plus more severe bi-allelic disease reported, animal models. Onset in infancy reported.

MODERATE by ClinGen.
Created: 20 Aug 2021, 7:21 a.m.
Association with HCM: MODERATE evidence by ClinGen working group.

Via ClinGen: Associated with hypertrophic cardiomyopathy in 16 probands in 5 publications with some functional evidence in support (expression studies, in vitro assays, animal models).

Conflicting evidence for missense variants in particular: one of the variants p.Gly505Ser is present in >500 individuals in gnomad, including 7 homozygotes, and another novel missense variant was observed in an 86-year-old man, diagnosed with hypertrophic cardiomyopathy, in whom echocardiography and cardiac magnetic resonance imaging strongly suggested amyloidosis to be the underlying cause.
Created: 14 Oct 2020, 2:41 p.m.

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Cardiomyopathy, hypertrophic, MIM#613873; Cardiomyopathy, dilated, 2E, MIM# 619492

Publications

Paul De Fazio (Victorian Clinical Genetics Services)

I don't know

Moderate evidence by ClinGen working group.

Via ClinGen: Associated with hypertrophic cardiomyopathy in 16 probands in 5 publications with some functional evidence in support (expression studies, in vitro assays, animal models).

More recently a novel missense variant was observed in an 86-year-old man, diagnosed with hypertrophic cardiomyopathy, in whom echocardiography and cardiac magnetic resonance imaging strongly suggested amyloidosis to be the underlying cause.
Created: 29 Jul 2020, 10:06 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Cardiomyopathy, hypertrophic, MIM#613873

Publications

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • NHS GMS
Phenotypes
  • Cardiomyopathy, hypertrophic, MIM#613873
  • Cardiomyopathy, dilated, 2E, MIM# 619492
OMIM
605267
ClinGen
JPH2
DECIPHER
JPH2
Clinvar variants
Variants in JPH2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
20 Aug 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: JPH2 were changed from Cardiomyopathy, hypertrophic, MIM#613873 to Cardiomyopathy, hypertrophic, MIM#613873; Cardiomyopathy, dilated, 2E, MIM# 619492

20 Aug 2021, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: JPH2 were set to 30681346; 17509612; 23973696; 26869393; 28393127; 30235249

20 Aug 2021, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: JPH2 was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

14 Oct 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: jph2 has been classified as Amber List (Moderate Evidence).

14 Oct 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: JPH2 were changed from to Cardiomyopathy, hypertrophic, MIM#613873

14 Oct 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: JPH2 were set to

14 Oct 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: jph2 has been classified as Amber List (Moderate Evidence).

28 Jul 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: JPH2 was added gene: JPH2 was added to Cardiomyopathy_Paediatric. Sources: NHS GMS,Expert Review Green Mode of inheritance for gene: JPH2 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown